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Summary: 0~18 is a highly conserved major cytosolic phosphoprotein that is expressed at high 
levels in acute leukemia and in neuroblastoma. In this study we present evidence pointing to a role 
for Op18 in cellular proIiferation. Blocking of 0~18 mRNA translation using antisense 
oligonucleotides delayed entrance of mitotically stimulated normal peripheral blood lymphocytes 
into the S phase. Moreover treatment of HL-60 promyelocytic leukemia cells with DMSO or PMA 
which induced terminal differentiation resulted in a decrease in the level of 0~18 RNA and protein. 
Inhibition of lymphoid proliferation with cyclosporin afso resulted in reduced 0~18 levels. 0 1991 
Academic Press, Inc. 
We have previously undertaken studies aimed at identifying proteins that are altered in their 
expression in acute leukemia cells relative to non-leukemic proliferating cells of corresponding 
lineage. As a result, we have identified a major novel cytosolic phosphoprotein which we have 
designated 0~18 [I, 21. Our evidence to date indicates that Op 18 is overexpressed and does not 
get phosphorylated in acute leukemia to the extent it does in non-leukemic proliferating lymphoid 
cells that we have studied 131. Furthermore in neurobfastoma, we have observed a statistically 
significant correlation between diminished levels of 0~18 phosphorylation and N-myc oncogene 
copy number, suggesting a functional significance to 0~18 phosphorylation 121. It has been 
proposed that the 0~18 protein, also referred to as stathmin in the mouse plays a role in 
intracellular signal transduction 14-61. 
In previous studies we have reported the cloning and sequencing of 0~18 cDNA and 
genomic DNA and presented evidence that 0~18 is conserved and ubiquitous and that its 
overabundance in leukemia results from increased expression of a structurally unaltered gene [3, 
71. To determine the role of 0~18 in cell proliferation, we have examined the effect of inhibiting 
0~18 mRNA translation t!sing antisense o!igodeoxy:!I:cleotide:; o:! en r-8 of !ymphoid cel!s into the tJ 
S phase; we have also examined the effect of inhibiting lymphoid proliferation using cyclosporin, 
and the effect of inducing terminal differentiation of HL-60 leukemia cells using DMSO or PMA on 
the levels of 0~18. 
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&.terial and Methods 
All radioactive isotopes: [s2P]y ATP (>3000 Ci/mmol), [3*P]ad CTP (>3000 Ci/mmol), 
[methyl-3H] thymidine (47 Ci/mmol), L-[35S] methionine (>lOOO Ci/mmol) and the random 
primer labeling kit were purchased from Amersham. Magna NT nylon membranes were from 
Micron Separation Inc. Cell culture media were obtained from Irvine Scientific, GIBCO and Flow 
Laboratories; Ficoll-Paque was from Pharmacia. Cyclosporin (CSA) was purchased from Sandoz 
and phytohemagglutinin (PHA) was from Burroughs-Wellcome. Oligonucleotides were 
synthesized on Applied Biosystems Inc., automated DNA synthesizers employing P-cyanoethyl 
phosphoramidite chemistry on controlled pore glass support. The oligos were purified by reverse 
phase HPLC, and quantitated by spectrophotometry. The oligos were also 32P end labeled and 
analyzed on native 12% acrylamide gel to check their stability, 
Effect of 0~18 antisense olieos on cell oroliferation 
Antisense (AS) oligonucleotides (5’ ATC AGA AGA AGC CAT) complementary to the 
first 15 bases of 0~18 protein coding sequence were synthesized. As a control, nonsense (NS) 
oligonucleotides (5’ GAC ATA GAC ATA GAC) which have the same base composition as AS- 
oligos but in a scrambled arrangement were also synthesized. The nonsense oligos sequence did 
not match any sequence using the PIR databases. 
Resting normal lymphocytes were isolated from the venous blood of healthy individuals by 
Ficoll-Paque according to manufacturer’s protocol, and cultured in complete media (RPM1 + 10% 
Fetal bovine serum + 4 mM L-glutamine + 100 u/ml penicillin + 100 pg/pl streptomycin) in a 
tissue culture flask for 2 hrs. Lymphocytes which remained in suspension were separated from the 
monocyte layer that adhered to the culture flask. The lymphocytes were then counted and 
resuspended in complete media at a concentration of 2 x 106 cells/ml and aliquoted in a 24 well 
plate. 
Cells were treated with 25 PM of either antisense or nonsense oligos before stimulation 
with anti-CD3 (OKT3 ascites, l/1000). Untreated cells or cells stimulated with only OKT3 were 
used as controls. The culture medium was replenished every 12 hrs, and in the wells where cells 
were treated with oligos, 25 p,M of AS or NS oligos were also added. The rate of proliferation of 
cells incubated with antisense or nonsense oligos was determined by 3H thymidine incorporation 
and the DNA content of the cells was detemmined by flow cytometry. The rate of new protein 
synthesis in treated cells was determined by incubation of 3 x 105 celts with 100 FC!i of 35s 
methionine in 500 ~1 methionine free media for 4 hrs; equal numbers of TCA precipitable counts 
were separated by 2-D PAGE and followed by quantitative analysis of autoradiographs. 
Flow Cvtomeny 
At each time point, 0.5 x 106 cells per well were vigorously suspended and transferred to a 
plastic tube. The wells were then washed with standard buffer (1% FA buffer, 1% fetal calf 
serum, 10% NaN3; pH 7.15 - 7.25) which was then added to the cells. 2 ml of standard buffer 
were then added and the cells were collected by centrifugation for 5 min at 1000 rpm at 40 C. After 
decanting the supernate, the cell pellets were vortexed and 25 pl of chicken erythrocytes (CRBC- 
1.3 - 1.6 x 10e/ml), and 2 ml of standard buffer were added. The cells were then centrifuged as 
before and the supernate decanted. After vortexing. the cells were stained with 1 ml of propidium 
iodide (0.01 M Tris, 10 mM NaCl, 0.7 u/ml RNase, 7.5 x 10-5 M propidium iodide and 1 @/ml 
NP-40) vortexed and incubated on ice for 1 hr. The cells were then in 75 ~1 of 2% 
paraformaldehyde and their DNA content determined by flow cytometry [S-lo]. The data was 
analyzed using PARA 1 program [ 111. 
ZH thvmidine incorporation 
For each sample, three SO x 103 cells/well/l00 pl were labeled in complete media with 0.8 - 
1 pCi 3H thymidine/well for 4 hrs to 16 hrs. The cells were then harvested on glass fiber filters 
and counted in scintillation fluid. 
Effect of cvclosporin on the level of Ou 18 
Resting normal lymphocytes were isolated and cultured in complete media at a 
concentration of 2 x 106 cells/ml. In time course studies, cells were treated for 3 days with 0.5 pg 
- 1 1.18 cyclosporin (CsA) at the time of their stimulation with anti-CD3 (OKT3 ascites, 1:200). 
Resting lymphocytes and lymphocytes stimulated with OKT3 were used as controls. At each time 
point, the rate of proliferation was determined by 3H thymidine incorporation and the level of Op18 
was determined by quantitation of silver stained 2-D gels [ 121. 
Ouantification of 0~18 
Spot detection and quantitation of 0~18 were performed as previously described [ 131. The 
0~18 spots (Op18,Opl8a, Opl8b) as well as 15 other reference spots were quantified by placing 
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a cursor on each spot, on the graphics monitor and typing the name of the spot. The integrated 
intensity of each spot was measured in units of optical density times square millimeter. The 
reference spots were used to adjust the 0~18 spots integrated intensity as previously described [13] 
to compensate for any variability in protein loading or staining between gels. 
HL-60 Differentiation Exoeriments 
HL-60 cells were cultured in complete media and treated with 1.5% DMSO for 8 days and 
with 50 nM PMA for 5 days [14, 151. For each time point, the rates of cellular proliferation were 
determined by 3H thymidine uptake and cell aliquots were harvested and frozen at -800 C. 
Polypeptides of untreated controls and treated cells were analyzed by 2-D PAGE followed by silver 
staining [ 121. Total cellular RNA from untreated and treated cells were prepared by the guanidine 
thiocyanate method 1161 and analyzed by dot-blot hybridization. The filters were hybridized to 
0~18 cDNA, washed at high stringency and visualized by autoradiography. The membranes were 
stripped and re-probed with glyceraldehyde phosphate dehydrogenase (GADPH) cDNA as control 
[171. 
Results and Discussion 
While 0~18 is present in greater amount in acute leukemia cells relative to proliferating 
non-leukemic lymphoid cells, it still occurs as a major protein constituent in proliferating peripheral 
blood lymphocytes that have been stimulated with the mitogen PHA [ 11. Therefore in order to 
block the increase in 0~18 levels to a significant extent, in stimulated peripheral blood lymphocytes 
using 0~18 antisense oligonucleotides, we have compared the effect of PHA and of anti-CD3 
antibody (OKT3) on the proliferative response of peripheral blood lymphocytes and on the level of 
0~18. While some variability was observed in the proliferative response using either agent, 
stimulation with anti-CD3 antibody particularly at high dilution (l/1000) generally resulted in a 
more moderate proliferative response, as determined by 3H thymidine incorporation, and a more 
moderate increase in 0~18 levels, as determined by 2-D PAGE and RNA analysis, than with PHA. 
Three experiments were undertaken to determine the effect of 0~18 antisense oligos on 
proliferation in response to OKT3. Inhibition of proliferation in the presence of antisense oligos 
appeared to be dependent on the extent of stimulation achieved with the anti-CD3 antibody. In two 
time course experiments in which the proliferative response with anti-CD3 was moderate 3H 
thymidine uptake in the presence of antisense was significantly lower than with nonsense oligos 
with the same base composition. Data for one experiment for which flow cytometric analysis of 
DNA content was also undertaken is presented in Table 1. In a third experiment, a substantially 
greater proliferative response was observed in the presence of anti-CD3, and 3H thymidine 
incorporation in the presence of nonsense or antisense oligos was identical. 
Quantitative 2-D PAGE analysis of newly synthesized 35.S labeled Op 18 from the above 
experiments showed approximately a 50% reduction in antisense relative to nonsense treated cells 
within 60 hrs under conditions in which aliquots with an eqt~al number of counts were loaded onto 
gels. This indicated that 0~18 antisense oligos blocked 0~18 translation, thus causing a decrease 
in 0~18 polypeptide. In the same experiment we observed that the increment in the percentage of 
cells in the S phase following anti-CD3 treatment was reduced and delayed in cells treated with 
anti-sense relative to treated nonsense oligos cells. By 72 hours, twice as many cells had 
progressed to the G2 and M phases in non-sense as in antisense treated cells (23.36 vs 12.62 %, 
respectively). Our findings therefore are that in the presence of mild stimulation, 0~18 synthesis 
was sufficiently blocked to result in a measurable delay in cell proliferation and in 3H thymidine 
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Table 1. Effect of 0~18 antisense oligos on the proliferation of peripheral blood lymphocytes 





3H thymidine uptake Flow cvtometrv 
(CLllll‘) %GO/G 1 %S %G2+M 
821.4 94.13 4.13 1.12 
Nonsense 1027.9 x9.33 9.15 1.5 
24 hrs Antisense 1338.9 9.5.60 3.81 0. IX 
Nonsense 1495.1 94.65 5.1 1 0.22 
36 hrs Antisense 2026.7 93.3 1 6.40 0.28 
Nonsense 2121.0 X7.56 10.59 1.84 
48 hrs Antisense 2463.2 93.13 5.58 1.28 
Nonsense 390s. 1 x9.7 7.74 2.55 
60 hrs Antisense 2427.6 88.93 7.92 3.13 
Nonsense 7001.6 7x.24 18.26 3.49 
72 hrs Antisense 5650.0 72.82 14.54 12.62 
Nonsense 9752.7 62.24 14.39 23.36 
Resting normal lymphocytes were cultured in complete medi;l and treated wilh 25 pM antisense OI 
nonsense oligos for 12 hrs before addition of 1:100 OKT3 ascites. Aliquots were removed every 
12 hrs to measure the level of proliferation as detetmined by thymidine incorporation, and the DNA 
content as determined by flow cytometry (Materials and Methods Section). 
uptake. However, with massive stimulation, Op18 synthesis resultin, (r from the activation of the 
0~18 gene was not sufficiently inhibited to affect cell proliferation. 
In other experiments, we detemiined whether the block in cell proliferation caused by the 
immunophilin inhibitor cyclosporin A (CsA)is associated with a lack of increase in 0~18 protein in 
OKTl treated lymphocytes. CsA prevents r.l- t i= !p!mTip!i(>!l of gr!y 1 T ce!! activation genes, thus 
inhibiting the signal transduction pathway mediated by the T cell receptor 1 181. Results of these 
experiments showed that the increase in Op 1X which occurs beginning on day 2 following 
stimulation with anti CD-.?, did not occur in the presence of cyclosporin. There was also a 
reduction in 3H thymidine incorporation in the presence of CsA (Table 2). These results indicate 
that CsA prevents the activation of 0~18 gene which is observed in late Gl. 
HL-60 responds to a variety of inducing agents by ceasing to proliferate and giving rise to 
cells with some granulocytic or monocytic characteristics [ 191. In HL-60, the c-rn~c oncogene 
which is transcribed at high levels, shows ;L marked decrease in mRNA expression after treatment 
of cells with DMSO, retionic acid, vitamin D3 or phorbol esters rind also displays characteristics 
associated with normal cell maturation I191. We therefore examined the effect of inducers on 0~18 
levels and proliferation of HL-60 cells. Dot l3lot analysis of total cellular RNA from time course 
experiments showed that 0~18 mRNA levels drop sharply after 5 days of treatment with 1 .S% 
DMSO and after’2 days of PMA treatment. This decrease in Op 18 mRNA (Figure 1) is paralleled 
by a decrease in 0~18 polypeptide (Figure 2) and :I decrease in cellular proliferation as determined 
by TH thymidinc incorporation (Table 3). 
In previous studies we have shown that the 0111 X gene has a higher level of expression 
(RNA and protein) in actively prolifemtin g cells than in resting normal lymphocytes and that the 
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Table 2. Effect of cyclosporin (GA) on OKT3 treated peripheral blood lymphocytes 
Day Treatment Total 0~18 3H Thymidine 
(inrecrated intensities) Incorooration (cum) 
Experiment 1 2 OKT3 1.398 7180 
OKT3 + CsA 0.897 264 
3 OKT3 3.358 8302 
OKT3 + CsA 0.488 181 
Experiment 2 2 None ,834 454 
OKT3 7 A._ 152 _ 11564 
OKT3 + CsA ,828 433 
3 None 0.505 1397 
OKT3 3.127 14242 
OKT3 + CsA 0.617 1005 
Experiment 3 2 None 0.174 228 
OKT3 I.296 10829 
OKT3 + CsA 0.3 568 
3 OKT3 1.63 8080 
OKT3 + CsA 0.232 716 
Resting normal lymphocytes were isolated and cultured in complete media. Aliquots from 
unueated cells (None) or cells treated with anti-CD3 (OKT3) or anti-CD3 and cyclosporin (OKT3 
+ CsA) were collected. The amount of total Op IX in the different samples was quantitated as 
described in Materials and Method>. 3H thymidine uprake was used as a measure of cell 
proliferation. 
induction of Op18 mRNA occurs at a time when the cells ;W entering S-phase. In this paper we 
present evidence that progression of cells through the cell cycle is dependent on the occurrence of 
0~18 at high levels and that downregulation or ;I block in proliferation as in the case of HL-60 cells 
Figure 1. Dot Blot analysis of HL-60 RNA shows a decrease in 0~18 mRNA after induction 
with DMSO or PMA. 5 vg of total cellular RNA from untreated and induced HL-60 cells were 
hybridized to human 0~18 cDNA probe (panel A) or chick GADPH probe (panel B). Ctrl: 
untreated cells, D2: cells treated with 1.5% DMSO for 2 days, DS: cells treated with DMSO for 5 
days, D8: cells treated with DMSO for 8 days, P2: cells trested with SO nM PMA for 2 days and 
P5: cells treated with PMA for 5 days. 
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Figure 2. Close-up sections of silver stained 2-D gel partern of HL-60 polypeptides show a 
decrease in total 0~18 polypeptide after induction of cells with DMSO or PMA. Arrows point to 
unphosphorylated form of 0~18 (0~18) and the two major phosphorylated forms (Opl8a. 
Op18b). Ctrl: untreated cells, D2, DS, D8: cells treated with 1.5% DMSO for 2, 5 and 8 days 
respectively. P2 and P5 cells treated with SO nM PMA for 2 and 5 days respectively. 
treated with PMA or DMSO, and cyclosporin treatment OF lymphocytes stimulated with anti-CD3 is 
associated with reduced levels of 0~18. These findings together with the high degree of 
conservation of the gene and its high level of expression in leukemia and neuroblastoma which we 
have demonstrated, point to an important role for 01) 1 X in nom~al and malignant cell proliferation. 
Table 3. Effect of DMSO and PMA treatment in the level of cellular proliferation of 
HL-60 
Time 3H thymidine incorponition (cpm) 
Treatment 
None 1.5% DMSO SO nM PMA 
2 days 61,535 45,986 3,964 
5 days 47,918 1,649 1,569 
8 days 42,415 1,067 
I-&60 cells were untreated or treated with 1.5% DMSO or SO nM PMA for different 
time periods. Three aliquots (50 x 106 cells) from each sample were labeled with 3H 
thymidine for 4 hrs, harvested and counted as described in Material and Methods. 
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